Parameter
| Biomarker | TERT promoter | Full name | TERT promoter mutation | Molecular Type | Nucleic acid (DNA) |
|---|---|---|---|---|---|
| Molecular Formula | Macromolecule | Molecular Weight | / | Core Functional Dimensions | The prognosis and risk stratification |
| Disease | Thyroid Cancer | Disease Subtypes | / | ||
| Organ | Thyroid | Test Sample / Technology Platform | Tissue (NGS, Sanger sequencing) | ||
| Pathobiological Mechanisms | Enhance tumor proliferation and invasion ability | ||||
| Clinical Availability Status | In clinical validation: 20%-50% PDTC is present, which is an independent poor prognostic factor | ||||
| Notes and Dynamics | With the mutated BRAF/RAS mutations with elevated risk further | ||||